[go: up one dir, main page]

WO2013013902A3 - Procédé pour le traitement de la transpiration humaine à l'aide d'un sel de cation multivalent et d'un sel d'anion - Google Patents

Procédé pour le traitement de la transpiration humaine à l'aide d'un sel de cation multivalent et d'un sel d'anion Download PDF

Info

Publication number
WO2013013902A3
WO2013013902A3 PCT/EP2012/061876 EP2012061876W WO2013013902A3 WO 2013013902 A3 WO2013013902 A3 WO 2013013902A3 EP 2012061876 W EP2012061876 W EP 2012061876W WO 2013013902 A3 WO2013013902 A3 WO 2013013902A3
Authority
WO
WIPO (PCT)
Prior art keywords
composition
salt
anion
skin
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/EP2012/061876
Other languages
English (en)
Other versions
WO2013013902A2 (fr
Inventor
Odile Aubrun
Bruno Biatry
Laure Ramos-Stanbury
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
LOreal SA
Original Assignee
LOreal SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR1156657A external-priority patent/FR2978033B1/fr
Priority claimed from FR1156656A external-priority patent/FR2978032B1/fr
Application filed by LOreal SA filed Critical LOreal SA
Publication of WO2013013902A2 publication Critical patent/WO2013013902A2/fr
Publication of WO2013013902A3 publication Critical patent/WO2013013902A3/fr
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A61K8/24—Phosphorous; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A61K8/20—Halogens; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36—Carboxylic acids; Salts or anhydrides thereof
    • A61K8/365—Hydroxycarboxylic acids; Ketocarboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4906—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom
    • A61K8/4913—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom having five membered rings, e.g. pyrrolidone carboxylic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67—Vitamins
    • A61K8/673—Vitamin B group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67—Vitamins
    • A61K8/676—Ascorbic acid, i.e. vitamin C
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q15/00—Anti-perspirants or body deodorants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
    • A61K2800/88—Two- or multipart kits
    • A61K2800/882—Mixing prior to application
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
    • A61K2800/88—Two- or multipart kits
    • A61K2800/884—Sequential application

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Inorganic Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Cosmetics (AREA)

Abstract

La présente invention porte sur un procédé pour le traitement de la transpiration humaine, qui comprend : (i) soit le mélange extemporané d'au moins une composition A et d'au moins une composition B conditionnées séparément et l'application dudit mélange sur la surface de la peau ; (ii) soit l'application sur la surface de la peau, simultanément ou séquentiellement, d'au moins une composition A et d'au moins une composition B conditionnées séparément ; ladite composition A comprenant au moins un halogénure de cation multivalent ; ladite composition B comprenant au moins un sel non azoté d'un anion ; ledit halogénure et ledit sel d'anion formant in situ, sur la peau, par interaction ionique cation/anion, un sel anti-transpirant. La présente invention porte également sur un procédé pour le traitement de la transpiration humaine résultant de la transpiration, qui comprend au moins : (i) soit le mélange extemporané d'au moins une composition A' et d'au moins une composition B' conditionnées séparément et l'application dudit mélange sur la surface de la peau ; (ii) soit l'application sur la surface de la peau, simultanément ou séquentiellement, d'au moins une composition A' et d'au moins une composition B' conditionnées séparément ; ladite composition A' comprenant au moins un sel non halogéné de cation multivalent ; ladite composition B' comprenant au moins un sel d'anion ; ledit sel de cation multivalent et ledit sel d'anion formant in situ, sur la peau, par interaction ionique cation/anion, un sel anti-transpirant.
PCT/EP2012/061876 2011-07-22 2012-06-20 Procédé pour le traitement de la transpiration humaine à l'aide d'un sel de cation multivalent et d'un sel d'anion Ceased WO2013013902A2 (fr)

Applications Claiming Priority (8)

Application Number Priority Date Filing Date Title
FR1156657A FR2978033B1 (fr) 2011-07-22 2011-07-22 Procede de traitement de la transpiration humaine utilisant un sel forme a partir d'un sel non halogene de cation multivalent et d'un sel d'anion
FR1156656A FR2978032B1 (fr) 2011-07-22 2011-07-22 Procede de traitement de la transpiration humaine utilisant un halogenure de cation multivalent et un sel non azote d'anion
FR1156657 2011-07-22
FR1156656 2011-07-22
US201161511699P 2011-07-26 2011-07-26
US201161511730P 2011-07-26 2011-07-26
US61/511,730 2011-07-26
US61/511,699 2011-07-26

Publications (2)

Publication Number Publication Date
WO2013013902A2 WO2013013902A2 (fr) 2013-01-31
WO2013013902A3 true WO2013013902A3 (fr) 2013-11-14

Family

ID=47601590

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2012/061876 Ceased WO2013013902A2 (fr) 2011-07-22 2012-06-20 Procédé pour le traitement de la transpiration humaine à l'aide d'un sel de cation multivalent et d'un sel d'anion

Country Status (1)

Country Link
WO (1) WO2013013902A2 (fr)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2745829B1 (fr) * 2011-09-28 2019-02-06 Unilever PLC Compositions anti-transpirantes et procédé pour réduire la transpiration
WO2014137350A1 (fr) * 2013-03-08 2014-09-12 Monroe Manus Bernard Sels de citrate utilisables en vue de l'élimination des odeurs
US20160045406A1 (en) * 2013-04-03 2016-02-18 Conopco, Inc., D/B/A Unilever Method for the manufacture of anhydrous cosmetic compositions
CN106999367B (zh) 2014-12-15 2020-05-05 荷兰联合利华有限公司 止汗剂组合物
EP3223914B1 (fr) 2014-12-26 2020-05-06 Colgate-Palmolive Company Complexe zinc-phosphate
CN107106425B (zh) 2014-12-26 2021-01-22 高露洁-棕榄公司 具有磷酸锌活性物的个人护理组合物
EP3223913B1 (fr) 2014-12-26 2021-12-01 Colgate-Palmolive Company Complexe de phosphate de zinc
CN107106428B (zh) 2014-12-26 2020-07-03 高露洁-棕榄公司 磷酸锌络合物
FR3072029A1 (fr) 2017-10-09 2019-04-12 L'oreal Procede de traitement de la transpiration humaine utilisant un cation et un anion en presence d'un modulateur
WO2020187686A1 (fr) 2019-03-18 2020-09-24 Unilever N.V. Composition antitranspirante comprenant des sels réactifs
MX2021011175A (es) 2019-03-18 2021-10-22 Unilever Ip Holdings B V Una composicion antitranspirante que comprende sales reactivas.
FR3117804B1 (fr) * 2020-12-22 2024-03-01 Oreal Procede de traitement de la transpiration humaine et des odeurs corporelles utilisant de l’oxyde de magnesium et un sel de phosphate
FR3157122A1 (fr) * 2023-12-22 2025-06-27 L'oreal Procédé de traitement de la transpiration humaine et composition associée

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2940062A1 (fr) * 2008-12-19 2010-06-25 Oreal Agent multi composants anti-transpirant comprenant deux composes capables de reagir par interaction physique et procede de traitement de la transpiration humaine en deux etapes

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0233140B1 (fr) 1986-01-10 1989-11-08 Ciba-Geigy Ag Additifs pour lubrifiants contenant du soufre et de l'azote
FR2668080B1 (fr) 1990-10-17 1993-08-13 Seppic Sa Compositions auto-emulsionnables a base d'alcools gras, leur procede de preparation et leur utilisation pour la realisation d'emulsions.
JP2631772B2 (ja) 1991-02-27 1997-07-16 信越化学工業株式会社 新規なシリコーン重合体及びそれを用いた水分散能を有するペースト状シリコーン組成物
EP0545002A1 (fr) 1991-11-21 1993-06-09 Kose Corporation Polymère de silicone, composition pâteuse et composition cosmétique du type eau-dans-l'huile le contenant
FR2712595B1 (fr) 1993-11-19 1995-12-22 Seppic Sa Un concentré comportant des alkylglycosides et ses utilisations.
US5837793A (en) 1996-03-22 1998-11-17 Dow Corning Toray Silicone Co., Ltd. Silicone rubber powder and method for the preparation thereof
US5874069A (en) 1997-01-24 1999-02-23 Colgate-Palmolive Company Cosmetic composition containing silicon-modified amides as thickening agents and method of forming same
US5919441A (en) 1996-04-01 1999-07-06 Colgate-Palmolive Company Cosmetic composition containing thickening agent of siloxane polymer with hydrogen-bonding groups
US5783657A (en) 1996-10-18 1998-07-21 Union Camp Corporation Ester-terminated polyamides of polymerized fatty acids useful in formulating transparent gels in low polarity liquids
FR2756176B1 (fr) 1996-11-26 1998-12-18 Oreal Composition cosmetique comprenant un compose fluore et presentant un confort ameliore
US5811487A (en) 1996-12-16 1998-09-22 Dow Corning Corporation Thickening silicones with elastomeric silicone polyethers
FR2762317B1 (fr) 1997-04-21 1999-07-09 Seppic Sa Composition a base d'alkylpolyglycosides et d'alcools gras, et ses utilisations
US6051216A (en) 1997-08-01 2000-04-18 Colgate-Palmolive Company Cosmetic composition containing siloxane based polyamides as thickening agents
US5981680A (en) 1998-07-13 1999-11-09 Dow Corning Corporation Method of making siloxane-based polyamides
FR2792190B1 (fr) 1999-04-16 2001-09-28 Sophim Procede de fabrication d'un emollient non gras a base de cires-esters
AU2002230016A1 (en) 2000-12-12 2002-06-24 L'oreal S.A. Cosmetic composition comprising a polymer and fibres
WO2002056847A1 (fr) 2001-01-17 2002-07-25 L'oreal Composition cosmetique contenant un polymer et une huile fluoree
JP4490817B2 (ja) 2002-09-12 2010-06-30 信越化学工業株式会社 新規なオルガノポリシロキサン重合物及びペースト状組成物並びにその組成物を用いた化粧料
US20070196303A1 (en) 2006-02-17 2007-08-23 Reheis, Inc. Stable buffered aluminum compositions having high hplc bands iii and iv containing calcium/strontium
DE102008012457A1 (de) 2007-06-19 2008-12-24 Cognis Ip Management Gmbh Kohlenwasserstoff Gemische und ihre Verwendung

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2940062A1 (fr) * 2008-12-19 2010-06-25 Oreal Agent multi composants anti-transpirant comprenant deux composes capables de reagir par interaction physique et procede de traitement de la transpiration humaine en deux etapes

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
DATABASE GNPD [online] Mintel; December 2004 (2004-12-01), "Talcum Powder Deodorant", XP002674211, Database accession no. 10202998 *
DATABASE GNPD [online] Mintel; July 2010 (2010-07-01), "Baking Soda Roll-On Deodorant", XP002674210, Database accession no. 1367919 *

Also Published As

Publication number Publication date
WO2013013902A2 (fr) 2013-01-31

Similar Documents

Publication Publication Date Title
WO2013013902A3 (fr) Procédé pour le traitement de la transpiration humaine à l'aide d'un sel de cation multivalent et d'un sel d'anion
MX2013008702A (es) Composiciones que contienen anticuerpos glicosilados y sus usos.
BR112014002884A2 (pt) composição para estimulação ovariana controlada
PH12014502406B1 (en) Anti-il-23p19 antibodies
BR112013002334A2 (pt) método para purificar polipeptídeos ou imunoconjugados ativos.
WO2013013999A3 (fr) Utilisation, comme anti-transpirant, d'un sel de cation multivalent sans anti-transpirant de type halogénure d'aluminium ou composé apte à réagir avec ledit sel afin de produire un effet anti-transpirant
EP4616914A3 (fr) Polypeptides se liant au complément humain c5
WO2012149412A3 (fr) Anticorps anti-endogline (cd105), immunoconjugués et leurs utilisations
EA201790876A1 (ru) Способ контроля, предотвращения или лечения кровотечения
BR112018069876A2 (pt) composição cosmética, método para fotoestabilização de resveratrol, polidatina, ou uma mistura dos mesmos com baicalina e método
WO2014012007A3 (fr) Agents de liaison des protéines rspo3 et leurs utilisations
WO2013188847A8 (fr) Compositions et procédés pour l'absorption transmucosale
BR112015010772A2 (pt) composição de enxágue tópica, uso de uma composição e método para tratar ou melhorar a pele de um indivíduo contra a acne
EP4414376A3 (fr) Nouveau depsipeptide et ses utilisations
MX391136B (es) FRAGMENTOS DE OspA ESTABILIZADOS CON CISTEÍNA Y MÉTODO DE USO
MY196718A (en) Composition for skin whitening comprising b-mangostin as effective ingredient
PH12015501360A1 (en) Bmp-6 antibodies
HK1209105A1 (en) Vegfr3 inhibitors
WO2013045270A3 (fr) Compositions antitranspirantes et procédé pour diminuer la transpiration
WO2013002565A3 (fr) Système de décoration d'ongles virtuelle, et procédé permettant un service de décoration d'ongles virtuelle utilisant ce dernier
HK1209104A1 (en) Vegfr3 inhibitors
WO2013121279A3 (fr) Procédé de préparation d'ertapénem
FR2978032B1 (fr) Procede de traitement de la transpiration humaine utilisant un halogenure de cation multivalent et un sel non azote d'anion
WO2013174725A3 (fr) Composition cosmétique comprenant la combinaison d'un dérivé lipophile d'acide salicylique, d'un sel ou d'un complexe d'aluminium antitranspirant et d'un sel d'acide (acide aminé)-n,n-diacétique
WO2015144997A8 (fr) Composition cosmetique et/ou dermatologique pour la coloration de la peau

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 12730881

Country of ref document: EP

Kind code of ref document: A2

122 Ep: pct application non-entry in european phase

Ref document number: 12730881

Country of ref document: EP

Kind code of ref document: A2